Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.
Set Alert for Articles By Tom Gallen

Latest From Tom Gallen

Recordati’s OTC Sales Lifted by Acquisitions And Italy

Italy's Recordati enjoyed strong growth in its home market and abroad, lifting OTC group sales in 2019.

Sales & Earnings Italy

COVID-19 Prompts OTC Sales Restrictions Across Europe

Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.

Coronavirus COVID-19 Europe

RB Implores Australian Consumers To Stop Panic Buying Its Brands

Reckitt Benckiser has seen an unprecedented increase in demand for its OTCs since the COVID-19 outbreak and is urging Australian consumers to stop panic buying so its partners can restock stores.

Australia Coronavirus COVID-19

Podcast: COVID-19's Impact On The European Consumer Health Market

As the coronavirus continues to spread across Europe, HBW Insight editors Tom Gallen and David Ridley discuss how the pandemic is impacting the region's consumer healthcare market. 

Coronavirus COVID-19 Europe

Hypera Immediately Offloads Takeda Brands To Concentrate On Brazil

Hypera is offloading a basket of brands it recently acquired from Takeda which are sold primarily in Mexico to São Paulo-based Eurofarma. 

Mexico Deals

EMA Reviewing Two Centralised Switch Applications

Teva's Ratiopharm and Italy's Recordati have submitted applications to switch drugs from prescription-to-OTC status through EMA's centralised procedure. Given only four products have been switched centrally to date, a double reclassification would be unprecedented. 

Prescription To Otc Switch Europe
See All
UsernamePublicRestriction

Register